Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide. - Draeger KE; Wernicke-Panten K; Lomp HJ; Schüler E; Rosskamp R (Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996)